Virginia Retirement Systems’s BioMarin Pharmaceuticals BMRN Stock Holding History

Virginia Retirement Systems’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.11M	Buy	89,320 +82,520	+1,214%	+$4.52M	0.03%	308
2026 Q1	$384K	Buy	+6,800	New	+$396K	﹤0.01%	813
2025 Q4	–	Sell	-224,700	Closed	-$12.2M	–	961
2025 Q3	$12.2M	Sell	224,700 -133,800	-37%	-$7.65M	0.08%	220
2025 Q2	$19.7M	Buy	358,500 +253,000	+240%	+$14.9M	0.14%	178
2025 Q1	$7.46M	Buy	+105,500	New	+$7.1M	0.06%	252
2022 Q1	$910K	Buy	+11,800	New	+$987K	0.01%	670
2015 Q4	$359K	Buy	3,425 +48	+1%	+$5.01K	0.01%	799
2015 Q3	$356K	Buy	3,377 +59	+2%	+$7.88K	0.01%	782
2015 Q2	$454K	Buy	3,318 +69	+2%	+$8.55K	0.01%	740
2015 Q1	$405K	Buy	3,249 +221	+7%	+$23.4K	0.01%	757
2014 Q4	$274K	Buy	3,028 +26	+0.9%	+$2.16K	﹤0.01%	840
2014 Q3	$217K	Buy	+3,002	New	+$197K	﹤0.01%	899
2013 Q3	–	Sell	-3,964	Closed	-$221K	–	831
2013 Q2	$221K	Buy	+3,964	New	+$247K	﹤0.01%	900

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Virginia Retirement Systems's BMRN Position: Q2 2026 in Review

Virginia Retirement Systems increased its BioMarin Pharmaceuticals (BMRN) stake by 1,214% in Q2 2026, buying an estimated $4.52M and bringing the position to 89,320 shares worth $5.11M. The position accounts for 0.03% of the portfolio, ranked #308.

Virginia Retirement Systems first reported a position in BMRN in Q2 2013 and has held it in 13 quarters since. The position peaked at $19.7M in Q2 2025. 564 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

Virginia Retirement Systems held 89,320 shares of BioMarin Pharmaceuticals worth $5.11M as of Q2 2026.
Virginia Retirement Systems bought 82,520 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $4.52M.
BioMarin Pharmaceuticals made up 0.03% of Virginia Retirement Systems's portfolio in Q2 2026, its #308 holding.
Virginia Retirement Systems first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 13 quarters since.
Virginia Retirement Systems's BioMarin Pharmaceuticals position peaked at $19.7M in Q2 2025.
564 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.